IP Library Granted Patent US 10,954,275
Granted Patent B1
US 10,954,275 · App. 16/054,882 · Granted Mar 23, 2021

Designed proteins for pH switchable antibody purification

Inventors: Ramesh Jha (Los Alamos, NM); Charlie Strauss (Los Alamos, NM); Andrew M. Bradbury (Los Alamos, NM)
Assignee: Triad National Security, LLC
C07K14/315C07K1/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,954,275
App. No.
16/054,882
Granted
Mar 23, 2021
Kind
B1
Abstract

Modified Fc-binding domain polypeptides or polypeptides including one or more modified Fc-binding domains are provided. In some examples, a modified Fc-binding domain includes or consists of the amino acid sequence of any one of SEQ ID NOs: 4, 6, or 8. Nucleic acids encoding the modified Fc-binding domains or polypeptides including one or more of the modified Fc-binding domains are also provided. In some embodiments, the nucleic acids are included in a vector and may be operably linked to a promoter. Methods for purifying a polypeptide including one or more Fc regions are also provided. Kits and reagents including the modified Fc-binding domain polypeptides or polypeptides including one or more modified Fc-binding domains are provided. In some examples, the modified Fc-binding domain polypeptides or polypeptides including one or more modified Fc-binding domains are linked to a solid support.

Claims (22)

1. A modified Fc-binding domain polypeptide comprising the amino acid sequence of SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8.

2. The modified Fc-binding domain polypeptide of claim 1 , wherein the modified Fc-binding domain consists of the amino acid sequence of SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8.

3. A nucleic acid encoding the modified Fc-binding domain polypeptide of claim 1 .

4. The nucleic acid of claim 3 , comprising the nucleic acid sequence of any one of SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7.

5. An immunoglobulin-binding protein comprising one or more modified Fc-binding domain polypeptides of claim 1 .

6. The immunoglobulin-binding protein of claim 5 , comprising the amino acid sequence of any one of SEQ ID NOs: 10-12.

7. A nucleic acid encoding the immunoglobulin-binding protein of claim 5 .

8. The nucleic acid of claim 7 , comprising the nucleic acid sequence of any one of SEQ ID NOs: 13-15.

9. A vector comprising the nucleic acid of claim 3 , operably linked to a promoter.

10. The modified Fc-binding domain polypeptide of claim 1 or an immunoglobulin-binding protein comprising one or more of the modified Fc-binding domain polypeptides, linked to a solid support.

11. The modified Fc-binding domain polypeptide or the immunoglobulin-binding protein linked to a solid support of claim 10 , wherein the solid support comprises agarose, sepharose, or polyacrylamide.

12. A kit comprising the modified Fc-binding domain polypeptide or the immunoglobulin-binding protein linked to a solid support of claim 10 and one or more buffers.

13. The kit of claim 12 , wherein the one or more buffers comprises an elution buffer with a pH of about 7-8.2.

14. A method of purifying a polypeptide including one or more Fc regions, comprising:

contacting the modified Fc-binding domain polypeptide of claim 1 or an immunoglobulin-binding protein comprising one or more of the modified Fc-binding domain polypeptides with a polypeptide including one or more Fc regions at a pH of about 6 or less to form a complex of the modified Fc-binding domain or the immunoglobulin-binding protein and the polypeptide including one or more Fc regions; and

contacting the complex with a buffer above about pH 7 to dissociate the polypeptide including one or more Fc regions.

15. The method of claim 14 , wherein the modified Fc-binding domain polypeptide or the immunoglobulin-binding protein is linked to a solid support.

16. The method of claim 14 , wherein the modified Fc-binding domain polypeptide or the immunoglobulin-binding protein is contacted with the polypeptide including one or more Fc regions at a pH of about 5.6.

17. The method of claim 14 , wherein the buffer above about 6 pH 7 to dissociate the polypeptide including one or more Fc regions comprises a buffer with pH about 8.2.

18. The nucleic acid of claim 4 , consisting of the nucleic acid sequence of any one of SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7.

19. The immunoglobulin-binding protein of claim 6 , consisting of the amino acid sequence of any one of SEQ ID NOs: 10-12.

20. The nucleic acid of claim 8 , consisting of the nucleic acid sequence of any one of SEQ ID NOs: 13-15.

Assignments (3)
CONFIRMATORY LICENSE Recorded May 18, 2020
From: TRIAD NATIONAL SECURITY, LLC
To: U.S. DEPARTMENT OF ENERGY
Reel/Frame 052686/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2018
From: LOS ALAMOS NATIONAL SECURITY, LLC
To: TRIAD NATIONAL SECURITY, LLC
Reel/Frame 048007/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2018
From: JHA, RAMESH; STRAUSS, CHARLIE; BRADBURY, ANDREW M.
To: LOS ALAMOS NATIONAL SECURITY, LLC
Reel/Frame 046566/0344 →
Continuity (1)
Provisional Application 62541414 · Aug 4, 2017